In ALS, mutations in proteins such as the Transactive response DNA binding protein of 43 kDa (TDP-43) and Fused in Sarcoma (FUS) disrupt their functional phase behaviour, resulting in the formation of toxic solid-like aggregates that compromise cellular function30–36. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.